0001193805-19-000400.txt : 20190422
0001193805-19-000400.hdr.sgml : 20190422
20190422183549
ACCESSION NUMBER: 0001193805-19-000400
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190412
FILED AS OF DATE: 20190422
DATE AS OF CHANGE: 20190422
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Neermann Joerg
CENTRAL INDEX KEY: 0001773900
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36201
FILM NUMBER: 19760331
MAIL ADDRESS:
STREET 1: IMMUNIC AG
STREET 2: AM KLOPFERSPITZ 19
CITY: MARTINSRIED
STATE: 2M
ZIP: 82152
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNIC, INC.
CENTRAL INDEX KEY: 0001280776
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562358443
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: AM KLOPFERSPITZ 19
CITY: MARTINSRIED
STATE: 2M
ZIP: 82152
BUSINESS PHONE: 49 89 250079460
MAIL ADDRESS:
STREET 1: AM KLOPFERSPITZ 19
CITY: MARTINSRIED
STATE: 2M
ZIP: 82152
FORMER COMPANY:
FORMER CONFORMED NAME: VITAL THERAPIES INC
DATE OF NAME CHANGE: 20040219
3
1
e618388_3-jorg.xml
X0206
3
2019-04-12
1
0001280776
IMMUNIC, INC.
IMUX
0001773900
Neermann Joerg
AM KLOPFERSPITZ 19
MARTINSRIED MUNICH
82152
1
0
0
0
On April 12, 2019, pursuant to an Exchange Agreement, dated as of January 6, 2019, between the Issuer (then known as Vital Therapies, Inc.), Immunic AG ("Immunic"), and the shareholders of Immunic party thereto (the "Exchange Agreement"), the holders of Immunic ordinary shares exchanged all of their outstanding shares for shares of Issuer common stock, resulting in Immunic becoming a wholly-owned subsidiary of the Issuer (the "Transaction"). Immediately following the Transaction, the Issuer changed its name to "Immunic, Inc." In connection with the Transaction, the Reporting Person was appointed Director of the Issuer.
/s/ Joerg Neerman
2019-04-22